469 related articles for article (PubMed ID: 22764318)
1. Impact of capsid modifications by selected peptide ligands on recombinant adeno-associated virus serotype 2-mediated gene transduction.
Naumer M; Popa-Wagner R; Kleinschmidt JA
J Gen Virol; 2012 Oct; 93(Pt 10):2131-2141. PubMed ID: 22764318
[TBL] [Abstract][Full Text] [Related]
2. Development and validation of novel AAV2 random libraries displaying peptides of diverse lengths and at diverse capsid positions.
Naumer M; Ying Y; Michelfelder S; Reuter A; Trepel M; Müller OJ; Kleinschmidt JA
Hum Gene Ther; 2012 May; 23(5):492-507. PubMed ID: 22171602
[TBL] [Abstract][Full Text] [Related]
3. Peptide ligands incorporated into the threefold spike capsid domain to re-direct gene transduction of AAV8 and AAV9 in vivo.
Michelfelder S; Varadi K; Raupp C; Hunger A; Körbelin J; Pahrmann C; Schrepfer S; Müller OJ; Kleinschmidt JA; Trepel M
PLoS One; 2011; 6(8):e23101. PubMed ID: 21850255
[TBL] [Abstract][Full Text] [Related]
4. Heparan Sulfate Binding Promotes Accumulation of Intravitreally Delivered Adeno-associated Viral Vectors at the Retina for Enhanced Transduction but Weakly Influences Tropism.
Woodard KT; Liang KJ; Bennett WC; Samulski RJ
J Virol; 2016 Nov; 90(21):9878-9888. PubMed ID: 27558418
[TBL] [Abstract][Full Text] [Related]
5. Insertional mutagenesis of the adeno-associated virus type 2 (AAV2) capsid gene and generation of AAV2 vectors targeted to alternative cell-surface receptors.
Shi W; Arnold GS; Bartlett JS
Hum Gene Ther; 2001 Sep; 12(14):1697-711. PubMed ID: 11560765
[TBL] [Abstract][Full Text] [Related]
6. Chimeric Capsid Proteins Impact Transduction Efficiency of Haploid Adeno-Associated Virus Vectors.
Chai Z; Zhang X; Dobbins AL; Frost EA; Samulski RJ; Li C
Viruses; 2019 Dec; 11(12):. PubMed ID: 31835440
[TBL] [Abstract][Full Text] [Related]
7. Novel random peptide libraries displayed on AAV serotype 9 for selection of endothelial cell-directed gene transfer vectors.
Varadi K; Michelfelder S; Korff T; Hecker M; Trepel M; Katus HA; Kleinschmidt JA; Müller OJ
Gene Ther; 2012 Aug; 19(8):800-9. PubMed ID: 21956692
[TBL] [Abstract][Full Text] [Related]
8. Vector Affinity and Receptor Distribution Define Tissue-Specific Targeting in an Engineered AAV Capsid.
Martino RA; Wang Q; Xu H; Hu G; Bell P; Arroyo EJ; Sims JJ; Wilson JM
J Virol; 2023 Jun; 97(6):e0017423. PubMed ID: 37199615
[TBL] [Abstract][Full Text] [Related]
9. RGD inclusion in VP3 provides adeno-associated virus type 2 (AAV2)-based vectors with a heparan sulfate-independent cell entry mechanism.
Shi W; Bartlett JS
Mol Ther; 2003 Apr; 7(4):515-25. PubMed ID: 12727115
[TBL] [Abstract][Full Text] [Related]
10. Improved Genome Packaging Efficiency of Adeno-associated Virus Vectors Using Rep Hybrids.
Mietzsch M; Eddington C; Jose A; Hsi J; Chipman P; Henley T; Choudhry M; McKenna R; Agbandje-McKenna M
J Virol; 2021 Sep; 95(19):e0077321. PubMed ID: 34287038
[TBL] [Abstract][Full Text] [Related]
11. Insertional mutagenesis at positions 520 and 584 of adeno-associated virus type 2 (AAV2) capsid gene and generation of AAV2 vectors with eliminated heparin- binding ability and introduced novel tropism.
Shi X; Fang G; Shi W; Bartlett JS
Hum Gene Ther; 2006 Mar; 17(3):353-61. PubMed ID: 16544984
[TBL] [Abstract][Full Text] [Related]
12. Genetic capsid modifications allow efficient re-targeting of adeno-associated virus type 2.
Girod A; Ried M; Wobus C; Lahm H; Leike K; Kleinschmidt J; Deléage G; Hallek M
Nat Med; 1999 Sep; 5(9):1052-6. PubMed ID: 10470084
[TBL] [Abstract][Full Text] [Related]
13. Molecular Engineering of Adeno-Associated Virus Capsid Improves Its Therapeutic Gene Transfer in Murine Models of Hemophilia and Retinal Degeneration.
Mary B; Maurya S; Kumar M; Bammidi S; Kumar V; Jayandharan GR
Mol Pharm; 2019 Nov; 16(11):4738-4750. PubMed ID: 31596095
[TBL] [Abstract][Full Text] [Related]
14. Successful expansion but not complete restriction of tropism of adeno-associated virus by in vivo biopanning of random virus display peptide libraries.
Michelfelder S; Kohlschütter J; Skorupa A; Pfennings S; Müller O; Kleinschmidt JA; Trepel M
PLoS One; 2009; 4(4):e5122. PubMed ID: 19357785
[TBL] [Abstract][Full Text] [Related]
15. Optimization of the capsid of recombinant adeno-associated virus 2 (AAV2) vectors: the final threshold?
Aslanidi GV; Rivers AE; Ortiz L; Song L; Ling C; Govindasamy L; Van Vliet K; Tan M; Agbandje-McKenna M; Srivastava A
PLoS One; 2013; 8(3):e59142. PubMed ID: 23527116
[TBL] [Abstract][Full Text] [Related]
16. Random peptide libraries displayed on adeno-associated virus to select for targeted gene therapy vectors.
Müller OJ; Kaul F; Weitzman MD; Pasqualini R; Arap W; Kleinschmidt JA; Trepel M
Nat Biotechnol; 2003 Sep; 21(9):1040-6. PubMed ID: 12897791
[TBL] [Abstract][Full Text] [Related]
17. Development of next generation adeno-associated viral vectors capable of selective tropism and efficient gene delivery.
Zhang C; Yao T; Zheng Y; Li Z; Zhang Q; Zhang L; Zhou D
Biomaterials; 2016 Feb; 80():134-145. PubMed ID: 26708090
[TBL] [Abstract][Full Text] [Related]
18. Context-Specific Function of the Engineered Peptide Domain of PHP.B.
Martino RA; Fluck EC; Murphy J; Wang Q; Hoff H; Pumroy RA; Lee CY; Sims JJ; Roy S; Moiseenkova-Bell VY; Wilson JM
J Virol; 2021 Sep; 95(20):e0116421. PubMed ID: 34346767
[TBL] [Abstract][Full Text] [Related]
19. SUMOylation Targets Adeno-associated Virus Capsids but Mainly Restricts Transduction by Cellular Mechanisms.
Chen Q; Njenga R; Leuchs B; Chiocca S; Kleinschmidt J; Müller M
J Virol; 2020 Sep; 94(19):. PubMed ID: 32669341
[TBL] [Abstract][Full Text] [Related]
20. Optimization of design and production strategies for novel adeno-associated viral display peptide libraries.
Körbelin J; Hunger A; Alawi M; Sieber T; Binder M; Trepel M
Gene Ther; 2017 Aug; 24(8):470-481. PubMed ID: 28622288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]